Neurocysticercosis
Open Access
- 29 April 2004
- journal article
- Published by SAGE Publications in Epilepsy Currents
- Vol. 4 (3), 107-111
- https://doi.org/10.1111/j.1535-7597.2004.43008.x
Abstract
Neurocysticercosis is a leading cause of seizures and epilepsy in the developing world and is an increasingly important health issue in the United States. Recent results from the Cysticercosis Working Group in Peru provide new evidence supporting the use of antiparasitic agents in highly selected patients with active cysts and seizures.Keywords
This publication has 32 references indexed in Scilit:
- Review of neurocysticercosisNeurosurgical Focus, 2002
- Deaths associated with cysticercosisNeurosurgical Focus, 2002
- Introduction to neurocysticercosis: a worldwide epidemicNeurosurgical Focus, 2002
- A population-based, case-control study of Taenia solium taeniasis and cysticercosisPathogens and Global Health, 1999
- Epilepsy in the Tropics: II. Clinical Presentations, Pathophysiology, Immunologic Diagnosis, Economics, and TherapyEpilepsia, 1996
- Epilepsy in the Tropics: I. Epidemiology, Socioeconomic Risk Factors, and EtiologyEpilepsia, 1996
- Is the course of neurocysticercosis modified by treatment with antihelminthic agents?Archives of Internal Medicine, 1995
- Neurocysticercosis as the main cause of late-onset epilepsy in MexicoArchives of Internal Medicine, 1990
- Cysticercosis in Los Angeles CountyJAMA, 1985
- Therapy of Parenchymal Brain Cysticercosis with PraziquantelNew England Journal of Medicine, 1984